REJECTION THERAPIES

被引：9

作者：

KLINTMALM, GB

机构：

[1] Transplantation Services Department of Surgery, Baylor University Medical Center, Dallas, 75246, Texas

来源：

DIGESTIVE DISEASES AND SCIENCES | 1991年 / 36卷 / 10期

关键词：

LIVERGRAFT; REJECTION; TREATMENT RESPONSE;

D O I：

10.1007/BF01296811

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

One hundred thirty-eight primary liver allograft recipients received cyclosporine and prednisolone immunosuppression with azathioprine added during the induction phase. All rejections were biopsy-confirmed clinical rejections. Acute rejection was seen in 58.7% of the patients. The treatment of acute rejection was successful in 88.9% of treated patients. Rejection-related death was seen in 4.3%, and retransplantation was performed for acute or chronic rejection in 2.2% of the patients. The risk for dying increased with the number of rejection treatments.

引用

页码：1431 / 1433

页数：3